Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

(6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine dihydrochloride monohydrate

EU orphan designation number: EU/3/09/616   
Active ingredient: (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine dihydrochloride monohydrate
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: Knopp Neurosciences Sub Ltd
c/o Gravitas Company Secretarial Services, One New Change, London EC4M 9AF, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/03/2009 Centralised Orphan - Designation EMEA/OD/096/08 (2009)1526 of 27/02/2009
11/03/2011 Centralised Orphan - Transfer of orphan designation EMEA/OD/096/08/T/01 (2011)1682 of 09/03/2011
25/11/2013 Centralised Orphan - Transfer of orphan designation EMEA/OD/096/08/T/02 (2013)8056 of 13/11/2013
02/01/2014 Corrigendum (2013)9816 of 20/12/2013